Aeon Biopharma Inc (AEON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,085 | 2,453 | 9,095 | 42,005 | 39,923 |
| Depreciation Amortization | 58 | 39 | 19 | 97 | 74 |
| Accounts payable and accrued liabilities | -3,385 | -2,003 | -3,473 | 2,522 | 1,242 |
| Other Working Capital | -5,841 | -5,273 | -5,810 | 706 | -2,589 |
| Other Operating Activity | -1,343 | -5,216 | -7,740 | -65,622 | -58,321 |
| Operating Cash Flow | $-12,596 | $-10,000 | $-7,909 | $-20,292 | $-19,671 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -4 | -4 | N/A | N/A |
| Investing Cash Flow | $-4 | $-4 | $-4 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 0 | 15,000 | 15,000 |
| Common Stock Issued | 18,514 | 18,430 | 18,346 | 147 | 50 |
| Financing Cash Flow | $18,514 | $18,430 | $18,346 | $15,147 | $15,050 |
| Beginning Cash Position | 13 | 13 | 13 | 5,158 | 5,158 |
| End Cash Position | 5,927 | 8,439 | 10,446 | 13 | 537 |
| Net Cash Flow | $5,914 | $8,426 | $10,433 | $-5,145 | $-4,621 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,596 | -10,000 | -7,909 | -20,292 | -19,671 |
| Capital Expenditure | -4 | -4 | -4 | N/A | N/A |
| Free Cash Flow | -12,600 | -10,004 | -7,913 | -20,292 | -19,671 |